Dr. Carl Nathan's work in Translational Medicine, supported by Milstein funding, is Recognized by Heritage Provider Network and Crain's New York Business
May 24th, 2017Dr. Carl Nathan is Professor and Chairman of the Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University. He directs the Abby and Howard P. Milstein Chemistry Core Facility and Program in Chemical Biology and Translational Medicine, and, subsequently, the Milstein Program in Medicinal Chemistry. Dr. Nathan was the founding director of the Tri-Institutional MD-PhD Program of Rockefeller University, Sloan Kettering Institute and Weill Cornell, and led the planning team for the Tri-Institutional Therapeutics Discovery Institute, where he is now a member of the Board of Directors.
With long-term support from the Howard and Abby Milstein Foundation, Dr. Nathan’s breakthrough research has identified one drug now in a clinical trial and another class of drugs advancing in pre-clinical trials that have the potential to shorten treatment time for TB by attacking the dormant bacteria that are thought to be largely responsible for the length and increasingly ineffective outcome of standard therapy.
Another sign of Dr. Nathan’s standing is the award to Weill Cornell of a $46 million, 7-year grant from the National Institutes of Health in support of the Tri-Institutional TB Research Unit led by Dr. Nathan. This award acknowledges that Dr. Nathan has assembled one of the world’s leading teams in fundamental, translational and clinical investigation in TB. The grant extends a continuous record of NIH funding of Dr. Nathan’s research over 39 years, support that has come from a diverse array of the Institutes: those for Cancer; Heart, Lung and Blood; General Medicine; and Allergy and Infectious Disease.
Dr. Nathan has served for 18 years as co-chair of the graduate program in Immunology and Microbial Pathogenesis at the Weill Graduate School of Medical Sciences of Cornell University, helping to instill habits of scientific excellence in hundreds of PhD students, including the 33 whom he has mentored in his own laboratory to date.
« Back